Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SARS Virus (pathogenicity) And NotTrenton Bushmaker

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000088 Yifei Xu [Royaume-Uni]Unveiling the Origin and Transmission of 2019-nCoV.
000105 Jeannette GuarnerThree Emerging Coronaviruses in Two Decades.
000110 Guangdi Li ; Erik De ClercqTherapeutic options for the 2019 novel coronavirus (2019-nCoV).
000119 Ying Liu [République populaire de Chine] ; Albert A. Gayle [Suède] ; Annelies Wilder-Smith [Allemagne, Suède] ; Joacim Rocklöv [Suède]The reproductive number of COVID-19 is higher compared to SARS coronavirus
000125 Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000188 Jiabao Xu ; Shizhe Zhao ; Tieshan Teng ; Abualgasim Elgaili Abdalla ; Wan Zhu ; Longxiang Xie ; Yunlong Wang [République populaire de Chine] ; Xiangqian GuoSystematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
000218 Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000245 Anu Haveri [Finlande] ; Teemu Smura [Finlande] ; Suvi Kuivanen [Finlande] ; Pamela Österlund [Finlande] ; Jussi Hepojoki [Suisse] ; Niina Ikonen [Finlande] ; Marjaana Pitk Paasi [Finlande] ; Soile Blomqvist [Finlande] ; Esa Rönkkö [Finlande] ; Anu Kantele [Finlande] ; Tomas Strandin [Finlande] ; Hannimari Kallio-Kokko [Finlande] ; Laura Mannonen [Finlande] ; Maija Lappalainen [Finlande] ; Markku Broas [Finlande] ; Miao Jiang [Finlande] ; Lotta Siira [Finlande] ; Mika Salminen [Finlande] ; Taneli Puumalainen [Finlande] ; Jussi Sane [Finlande] ; Merit Melin [Finlande] ; Olli Vapalahti [Finlande] ; Carita Savolainen-Kopra [Finlande]Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.
000399 Zhong Sun ; Karuppiah Thilakavathy ; S. Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis]Potential Factors Influencing Repeated SARS Outbreaks in China
000423 Julien Riou [Suisse] ; Christian L. Althaus [Suisse]Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020
000429 Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine]Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
000442 Al Giwa [États-Unis] ; Akash Desai [États-Unis]Novel coronavirus COVID-19: an overview for emergency clinicians
000627 Susan R. WeissForty years with coronaviruses
000716 Xuan Jiang [République populaire de Chine] ; Simon Rayner [Norvège] ; Min-Hua Luo [République populaire de Chine]Does SARS-CoV-2 has a longer incubation period than SARS and MERS?
000A93 J. L. Heeney [Pays-Bas]Zoonotic viral diseases and the frontier of early diagnosis, control and prevention
000B03 Ali A. Rabaan [Arabie saoudite] ; Shamsah H. Al-Ahmed [Arabie saoudite] ; Shafiul Haque [Arabie saoudite] ; Ranjit Sah [Népal] ; Ruchi Tiwari [Inde] ; Yashpal Singh Malik [Inde] ; Kuldeep Dhama [Inde] ; M Iqbal Yatoo [Inde] ; D Katterine Bonilla-Aldana ; Alfonso J. Rodriguez-Morales [Colombie]SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021